However, despite numerous preclinical and clinical studies that aim to develop TLR agonists into drugs for the treatment of infectious diseases, the effect of TLR induced IL-6 on virus-specific CD8+ T cell responses remains largely unknown. Here, IL6 is linked to infectious disease.